Tag - pharmaceuticals

 
Menu
Search
 
August 23, 2025
 

Today's print edition

Home Delivery
Subscribe for more access

PHARMACEUTICALS

Japan Times
WORLD / Science & Health / FOCUS
Aug 31, 2020
Scientists see downsides to top COVID-19 vaccines from Russia and China
High-profile COVID-19 vaccines developed in Russia and China share a potential shortcoming: They are based on a common cold virus that many people have been exposed to, potentially limiting their effectiveness, some experts say.
JAPAN / Science & Health
Aug 31, 2020
Daiichi Sankyo's COVID-19 vaccine candidate selected by Japanese drug discovery body
Daiichi Sankyo Co. said on Monday that its mRNA-based COVID-19 vaccine candidate was selected for inclusion in a drug discovery program by the Japan Agency for Medical Research and Development.
JAPAN / Society
Aug 28, 2020
Abe vows COVID-19 vaccinations for all Japan citizens by mid-2021
In view of the coming flu season, test kits will be provided at a volume that will allow for an average of 200,000 tests to be conducted every day.
Japan Times
BUSINESS / Companies
Aug 24, 2020
Takeda to sell consumer unit to Blackstone for ¥242 billion
Takeda Pharmaceutical Co. agreed to sell its Japanese consumer health care business for ¥242 billion ($2.3 billion) to Blackstone Group Inc., which plans to take the over-the-counter medication unit public in about five years.
Japan Times
WORLD / Science & Health
Aug 16, 2020
Coronavirus crisis has made Brazil an ideal vaccine laboratory
With a medical manufacturing infrastructure and plenty of vaccine trial volunteers, Brazil has emerged as a potentially vital player in the scramble to end the pandemic.
Japan Times
COMMENTARY / World
Aug 10, 2020
Vaccine confronts humanity with next moral test
Who gets coronavirus protection first (and last)? Who profits (and loses)? What is “informed consent” (if it exists)? Divided societies face agonizing choices.
Japan Times
COMMENTARY / World
Aug 5, 2020
Pricing COVID-19 vaccines too high could backfire on big pharma
If vaccine makers make their products too expensive for the developing world, the whole idea of intellectual property could be blown up.
JAPAN
Aug 4, 2020
Gargle medicine can fight coronavirus, Osaka governor says, citing limited data
The governor of Osaka Prefecture touted the powers of gargling medicine to control the coronavirus and recommended its use, sending related shares jumping and clearing shelves of disinfectants even as some questioned the findings.
Japan Times
BUSINESS / Companies
Jul 31, 2020
Taisho emerges as lead bidder for Takeda $3 billion consumer unit
Taisho Pharmaceutical Holdings Co. has emerged as the leading contender to acquire Takeda Pharmaceutical Co.’s Japanese consumer health care business, according to people familiar with the matter.
Japan Times
WORLD / Science & Health
Jul 30, 2020
Russia plans 'world's first approved' COVID-19 vaccine by Aug. 12
The conditional registration in August would still require trials to be conducted on another 1,600 people, and production is expected to begin in September.
Japan Times
BUSINESS / Companies
Jul 28, 2020
Astra to pay Daiichi up to $6 billion for new cancer drug
AstraZeneca is forging ahead to become a global oncology powerhouse, even as it works on a vaccine for the coronavirus pandemic.
Japan Times
WORLD / Science & Health
Jul 26, 2020
The supply chain to save the world is unprepared for a vaccine
The industries that shepherd goods around the world on ships, planes and trucks acknowledge they aren’t ready to handle the epic challenges of shipping an eventual COVID-19 vaccine from drugmakers to billions of people.
Japan Times
COMMENTARY / World
Jul 26, 2020
Britain's response to COVID-19 has been world class
One country has done more than any other to stop the spread of the coronavirus.
Japan Times
WORLD / Science & Health
Jul 21, 2020
Wave of promising study results raise hopes for coronavirus vaccines
Early data from trials of three potential COVID-19 vaccines released on Monday, including a closely watched candidate from Oxford University, increased confidence that a vaccine can train the immune system to recognize and fight the novel coronavirus without serious side effects.
Japan Times
BUSINESS / Companies
Jul 17, 2020
Japan in talks with Johnson & Johnson to secure COVID-19 vaccine
The company has already agreed to prioritize an allocation to the United States as part of a funding agreement, according to the firm's chief financial officer.
Japan Times
WORLD / FOCUS
Jul 17, 2020
Coronavirus cold war flares up with claims of Russian vaccine hack
The international race for protection from the virus escalated to a new level with allegations that vaccine development has become a target of Russian cyberattacks.
Japan Times
BUSINESS / Companies
Jul 14, 2020
Pfizer and BioNTech coronavirus vaccine candidates on FDA fast track
The U.S.-listed shares of the German firm climbed about 15 percent, while Pfizer's stock rose about 5 percent.
JAPAN / Science & Health
Jul 10, 2020
Avigan's effectiveness inconclusive in Japan COVID-19 trial
Promoted heavily by Prime Minister Shinzo Abe, the flu drug did not yield any statistically significant results after administered to 89 patients across Japan.
Japan Times
COMMENTARY / World
Jul 8, 2020
The fight over a coronavirus vaccine will get ugly
Once COVID-19 shots become available, there will be arguments about who gets them, and an even bigger battle with anti-vaxxers who refuse them.
Japan Times
WORLD / Science & Health
Jul 7, 2020
Moderna spars with U.S. scientists over COVID-19 vaccine trials
As the United States accelerates the search for a coronavirus vaccine, tensions have erupted between government scientists and Moderna Inc., one of the leading developers, it has been learned.
Japan to revise romanization rules for first time in 70 years
The Agency for Cultural Affairs is recommending replacing the government’s long-standing Kunrei system with more widely used Hepburn-style spellings.
JR East cancels luxury train run over crew's boozing
East Japan Railway said Thursday that it will cancel one trip of a luxury overnight sleeper service, which was originally scheduled to depart from Ueno Station in Tokyo on Aug. 30, after crew members were found to have been drinking alcohol on duty.
Demystifying the manufacturing success of China
China’s massive scale, strong education system and competitive local governance have enabled it to reach the technological frontier and dominate high-tech manufacturing despite its low per capita gross domestic product.
Infectious diseases to watch for in Japan this summer amid surge of cases
An illustration of a colony of the Bordetella pertussis bacterium that causes pertussis, or whooping cough. As of Aug. 10, there were 64,467 cases reported this year, according to the latest data from the Japan Institute for Health Security.
103-year-old remembers Soviet attack right after WWII
Shoichi Takahashi holds a photo of himself when he was younger, in Otaru, Hokkaido, on May 17.
Alicia Keys closed Summer Sonic, but J-pop owned it
Summer Sonic’s 2025 lineup demonstrated its strength, showcasing the latest in J-pop, including “new kawaii” act Fruits Zipper.
Big burgers and bigger ambitions for Japan's Burger King
Kazuhiro Nomura, president of BK Japan Holdings, which operates Burger King in Japan
Tokyo crowned No.1 'workation' spot
Workations were a burgeoning trend in the corporate world for years before the COVID-19 pandemic turbocharged it.
Atsushi Kitagawara’s exhibition finds poetry in architecture
The inverted cone, one of Atsushi Kitagawara’s six signature elements in architecture, is a key feature of the Nakamura Keith Haring Collection museum building.
Candidates preparing to make final pitches for Sawamura Award
Hawks pitcher Livan Moinelo has a 1.13 ERA in 19 starts this season.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

Tetsuzo Shiraishi, speaking at The Center of the Tokyo Raids and War Damage, uses a thermos to explain how he experienced the U.S. firebombing of March 1945, when he was just 7 years old.
From ashes to high-rises: A survivor’s account of Tokyo’s postwar past
By Alex K.T. Martin

SUSTAINABLE JAPAN

Looking ahead to Yokohama’s Green × Expo 2027
Looking ahead to Yokohama’s Green × Expo 2027

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER